Obesity Drug Makers Gears Up for Busy Sept. Conference Schedule (ARNA) (OREX) (VVUS)
Tweet Send to a Friend
Get Alerts OREX Hot Sheet
Trade OREX Now!
Like pharmaceutical conferences? Also enjoy companies that produce newly-approved obesity-control drugs? Then, have we got a list for you!
Below is a brief schedule of events coming up for the three big players in weight-loss pill technology: Orexigen (Nasdaq: OREX), VIVUS (Nasdaq: VVUS), and Arena Pharma (Nasdaq: ARNA).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Below is a brief schedule of events coming up for the three big players in weight-loss pill technology: Orexigen (Nasdaq: OREX), VIVUS (Nasdaq: VVUS), and Arena Pharma (Nasdaq: ARNA).
- September 5th: Citi 7th Annual Biotech Day event.
- September 5th - 6th: Stifel Nicolaus Healthcare Conference;
Presenters: Arena,, VIVUS
- September 7th: NewsMakers in the Biotech Industry;
Presenters: Arena, Orexigen, VIVUS
- September 10th - 11th: Rodman & Renshaw Annual Global Investment Conference in New York City
Presenters: Orexigen, VIVUS
- September 11th - 12th: Morgan Stanley Global Healthcare Conference in New York City;
Presenters: Orexigen, VIVUS
- September 13th: Bank of America Merrill Lynch Global Healthcare Conference in London;
Presenters: Orexigen, VIVUS, Arena.
Presenters: Orexigen, VIVUS
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Amarin's (AMRN) Vascepa Not in FDA Orange Book for April
- Apple (AAPL) Streaming Music Service Could be Delayed - The Verge
- UPDATE: Uni-Pixel (UNXL) Takes Beating in Friday Trading
Create E-mail Alert Related Categories
FDA, Trader TalkRelated Entities
Stifel Nicolaus, Citi, Morgan Stanley, Merrill Lynch, Bank of America, Rodman & RenshawLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Up)